Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03422679
Title Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Cellestia Biotech AG
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU | CHE

Facility Status City State Zip Country Details
Sarcoma Oncology Research Center Santa Monica California 90403 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
MD Anderson Houston Texas 77030 United States Details
Centre Hospitalier Lyon-Sud Lyon France Details
Hôpital Saint-Louis Paris 75475 France Details
Charite- Universitaetsmedizin Berlin- Campus Benjamin Franklin Berlin 10117 Germany Details
Universitätsklinikum Frankfurt Frankfurt 60590 Germany Details
Nationales Centrum für Tumorerkrankungen Heidelberg Heidelberg 69120 Germany Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Severance Hospital - Yonsei Cancer Center Seoul 03722 Korea, Republic of Details
Seoul National University Hospital Seoul 06351 Korea, Republic of Details
Hospital Quirón Barcelona Barcelona 08023 Spain Details
Vall d'Hebron Institute of Oncology (VHIO) Barcelona 08035 Spain Details
Catalan Institute of Oncology Barcelona 08916 Spain Details
Hospital Ramón y Cajal Madrid 28034 Spain Details
Oncology Institute of Southern Switzerland Bellinzona 6500 Switzerland Details
Kantonsspital St.Gallen Saint Gallen 9007 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field